Phase 2 Efficacy Study of Primaquine and Methylene Blue (Bamako, Mali) , ClinicalTrials.gov NCT02831023 (2016)

Government Record · Alassane Dicko / Malaria Research and Training Centre, University of Bamako; University of California San Francisco (lead sponsor) · July 2016

Alassane Dicko / Malaria Research, 2016-07: Registry entry for the Mali phase 2 trial that became the Dicko 2018 Lancet Infectious Diseases paper; completed, phase 2.

Phase 2 Efficacy Study of Primaquine and Methylene Blue

Registry record field

Alassane Dicko / Malaria Research, 2016-07: Registry entry for the Mali phase 2 trial that became the Dicko 2018 Lancet Infectious Diseases paper; completed, phase 2. Record field (brief title) transcribed from the API v2 record, hence MEDIUM. Status COMPLETED, phase 2, start July 2016; results published as Dicko et al., Lancet Infect Dis 2018 (see the PubMed row for that trial). Registered prospectively. Study type: regulatory record.